Targeting the transcriptional and translational machinery of the endosymbiotic organelle in apicomplexans
- PMID: 18991607
- DOI: 10.2174/138945008786786073
Targeting the transcriptional and translational machinery of the endosymbiotic organelle in apicomplexans
Abstract
Apicomplexans are obligate intracellular parasites causing devastating disease in both humans and livestock. Nearly all apicomplexans, with the exception of Cryptosporidium, contain two endosymbiontic organelles carrying their own DNA; the mitochondrion and the plastid-like organelle called the apicoplast. The apicoplast is an attractive drug target as it harbors not only metabolic pathways not found in the host cell, but it is also dependent on its ancient transcriptional and translational machinery. These parasites rely on the plastid, and inhibition of its function or loss of this organelle leads to immediate or delayed death. Replication of plastidic DNA shows differences between the members of this phylum. In Plasmodium parasites, two forms of replication are observed--unidirectional single-stranded replication and a rolling circle mechanism--whereas in Toxoplasma gondii only the rolling circle is found. Targeting enzymes involved in DNA-replication leads to a delayed death of the parasite. Most of the genes in the apicoplast genome encode elements of their own transcriptional and translational machinery, and they are highly similar to those found in bacteria. Several anti-bacterials which target this machinery are also active against apicomplexan parasites and inhibition leads mostly to the delayed death phenomenon.
Similar articles
-
Biosynthetic pathways of plastid-derived organelles as potential drug targets against parasitic apicomplexa.Curr Drug Targets Immune Endocr Metabol Disord. 2003 Jun;3(2):99-109. doi: 10.2174/1568008033340261. Curr Drug Targets Immune Endocr Metabol Disord. 2003. PMID: 12769782 Review.
-
The apicoplast as a potential therapeutic target in and other apicomplexan parasites.Parasitol Today. 1999 Jan;15(1):5-7. doi: 10.1016/s0169-4758(98)01363-5. Parasitol Today. 1999. PMID: 10234168 No abstract available.
-
Targeting Protein Translation in Organelles of the Apicomplexa.Trends Parasitol. 2016 Dec;32(12):953-965. doi: 10.1016/j.pt.2016.09.011. Epub 2016 Oct 25. Trends Parasitol. 2016. PMID: 27793563 Review.
-
The plastid-like organelle of apicomplexan parasites as drug target.Curr Pharm Des. 2008;14(9):855-71. doi: 10.2174/138161208784041105. Curr Pharm Des. 2008. PMID: 18473835 Review.
-
The apicoplast as a potential therapeutic target in Toxoplasma and other apicomplexan parasites: some additional thoughts.Parasitol Today. 1999 Jan;15(1):41. doi: 10.1016/s0169-4758(98)01367-2. Parasitol Today. 1999. PMID: 10234180 No abstract available.
Cited by
-
Drug target identification in protozoan parasites.Expert Opin Drug Discov. 2016 Aug;11(8):815-24. doi: 10.1080/17460441.2016.1195945. Epub 2016 Jun 16. Expert Opin Drug Discov. 2016. PMID: 27238605 Free PMC article. Review.
-
Targeting the gyrase of Plasmodium falciparum with topoisomerase poisons.Biochem Pharmacol. 2015 Jun 15;95(4):227-37. doi: 10.1016/j.bcp.2015.03.018. Epub 2015 Apr 13. Biochem Pharmacol. 2015. PMID: 25881748 Free PMC article.
-
Macrolides and associated antibiotics based on similar mechanism of action like lincosamides in malaria.Malar J. 2016 Feb 12;15:85. doi: 10.1186/s12936-016-1114-z. Malar J. 2016. PMID: 26873741 Free PMC article.
-
Babesia bovis: a bipartite signal directs the glutamyl-tRNA synthetase to the apicoplast.Exp Parasitol. 2012 Jun;131(2):261-6. doi: 10.1016/j.exppara.2012.04.013. Epub 2012 Apr 27. Exp Parasitol. 2012. PMID: 22561041 Free PMC article.
-
Toxoplasma gondii infection: novel emerging therapeutic targets.Expert Opin Ther Targets. 2023 Apr-May;27(4-5):293-304. doi: 10.1080/14728222.2023.2217353. Epub 2023 May 24. Expert Opin Ther Targets. 2023. PMID: 37212443 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources